Panion Animal Health
954 Lexington Avenue, #1005
New York, New York 10021
Carlos N. Velez
Director Business Development
Carlos Velez has direct experience in the sourcing, evaluation, and licensing of novel products, including animal health assets. He was previously the Chief Business Officer (CBO) of Lantix Therapeutics UK and has been Director of Business Development at Penwest Pharmaceuticals, where he was responsible for the out-licensing of 505(b)(2) programs as well as the scouting and analysis of neurology in-licensing opportunities. Other previous employers include Forest Labs, Frankel Group (now Huron Consulting) and Genencor International. Carlos holds a B.Sc. in Pharmacy from the Albany College of Pharmacy, a Ph.D. in Pharmacy from the University of North Carolina at Chapel Hill, and an MBA in Finance from the Rochester Institute of Technology.
US-based clinical trial monitor, consultant
Beth Oman has broad experience in the global development of pharmaceutical and biological products in companion animals and food animals. She has monitored and managed a variety of clinical studies including multi-location GCP studies. She worked for The Upjohn Company, Pharmacia & Upjohn, Pharmacia and Pfizer and has been an independent consultant since 2010. Beth holds a B.S. in Animal Science from Cornell University and a M.A. in Organizational Communication from Western Michigan University.
Steven V Radecki